Significant shareholders:

Shareholder/Beneficial OwnerShares% ISC
Lombard Odier Investment Managers141,593,74314.73
T Rowe Price Global Investments93,927,4659.77
Canaccord Genuity Wealth Management85,007,1258.84
Hargreaves Lansdown, stockbrokers60,782,0476.32
Dr Andrew Nelson*46,266,8814.81
Interactive Investor46,118,5404.80

as at 30 June 2023

Quoted: AIM (London Stock Exchange)

Other Exchanges / Trading Platforms: The Company is not listed on any other exchanges or trading platforms.

Number of securities in issue: 961,386,955 Ordinary shares.

Shares not in public hands: Insofar as the Company is aware, the percentage of securities that is not in public hands is 36.3%, these being held by directors, their families and significant shareholders.

Own shares held in treasury: The Company holds 4,115 Ordinary Shares in treasury.

Details on any restrictions on the transfer of securities: There are no restrictions on the transfer of securities.

Applicable code(s): The Company is subject to the UK City Code on Takeovers and Mergers. The Code is administered by The Panel and Takeovers in Mergers.

* Per the Company’s RNS announcement of 11 May 2020, 12,121,711 Ordinary Shares of Dr Nelson’s total beneficial interest are subject to a Sale and Repurchase Agreement with Equities First Holdings.